GSK seeks to extend shingles vaccine Shingrix to younger at-risk adults in China

GSK plc (LSE/NYSE: GSK) has reached a pivotal milestone in the prevention of shingles (herpes zoster) in China, with the Center for Drug Evaluation (CDE) ... Read More